Adenosine monophosphate bronchial provocation and the actions of asthma therapy.
Lee
D K C
DK
Asthma & Allergy Research Group, Ninewells Hospital & Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK.
Gray
R D
RD
Lipworth
B J
BJ
D000249:Adenosine Monophosphate; D000318:Adrenergic beta-Agonists / Q000494:pharmacology / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D015415:Biomarkers; D001985:Bronchial Provocation Tests / Q000379:methods*; D004205:Cromolyn Sodium; D016903:Drug Monitoring / Q000379:methods*; D006634:Histamine H1 Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D020024:Leukotriene Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D013256:Steroids; D013806:Theophylline / Q000494:pharmacology / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D006634:Histamine H1 Antagonists; D020024:Leukotriene Antagonists; D013256:Steroids; D000249:Adenosine Monophosphate; D013806:Theophylline; D004205:Cromolyn Sodium